DXCM Stock Cash Flow Statements

DexCom Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

DexCom Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31

operating activities
net income	179,800,000	105,400,000	151,700,000	134,600,000	143,500,000	146,400,000	256,300,000	120,700,000	115,900,000	48,600,000	91,800,000	101,200,000	50,900,000	97,300,000	-19,400,000	70,900,000	62,900,000	40,300,000	355,200,000	72,200,000	46,300,000	19,900,000	45,800,000	-10,500,000	-26,900,000	46,600,000	30,200,000	-24,200,000	-2,000,000	2,900,000	-41,700,000	-7,400,000	-18,800,000	-20,200,000	-19,200,000	1,500,000	-42,500,000	-3,700,000	-12,900,000	-5,200,000	-6,000,000	-12,500,000	-2,600,000	-6,000,000	-10,100,000	-11,100,000	-8,482,000	-17,263,000	-14,691,000	-14,064,000	-12,251,000	-13,278,000	-7,367,000	-11,850,000	-9,812,000	-13,398,000	-11,687,000	-20,273,000	-11,529,000	-13,523,000	-15,330,000	-13,142,000	-13,450,000	-14,688,000	-14,074,000	-12,972,000	-12,229,000
adjustments to reconcile net income to cash from operating activities:
depreciation and amortization	63,000,000	60,000,000	57,800,000	55,300,000	52,100,000	52,500,000	52,500,000	48,200,000	43,700,000	41,600,000	36,300,000	39,200,000	43,600,000	36,800,000	32,100,000	25,500,000	23,500,000	20,900,000	20,400,000	18,400,000	15,300,000	13,000,000	12,900,000	11,600,000	9,900,000	7,800,000	6,700,000	6,000,000	4,300,000	3,900,000	3,700,000	3,600,000	4,100,000	3,900,000	3,400,000	3,100,000	2,700,000	2,600,000	2,400,000	2,200,000	1,900,000	1,900,000	1,900,000	1,700,000	1,600,000	1,800,000	1,751,000	2,199,000	1,468,000	1,182,000	1,063,000	998,000	892,000	806,000	721,000	628,000	588,000	500,000	470,000	589,000	662,000	652,000	768,000	710,000	703,000	855,000	1,004,000
share-based compensation	45,300,000	34,200,000	43,300,000	43,400,000	44,700,000	39,000,000	36,900,000	39,000,000	39,700,000	35,200,000	34,000,000	30,800,000	32,600,000	29,100,000	26,300,000	27,500,000	31,600,000	28,000,000	34,100,000	30,700,000	30,700,000	23,900,000	24,400,000	29,700,000	25,000,000	27,100,000	25,600,000	24,600,000	25,400,000	25,300,000	30,600,000	29,100,000	29,000,000	27,600,000	25,100,000	23,500,000	22,600,000	20,700,000	15,900,000	13,800,000	13,200,000	8,700,000	6,600,000	6,600,000	6,400,000	5,000,000	4,542,000	4,879,000	4,833,000	4,146,000	3,580,000	3,728,000	3,657,000	2,548,000	2,078,000	2,317,000	2,771,000	2,275,000	2,154,000	2,130,000	2,041,000	2,041,000		1,787,000	1,972,000	1,948,000
non-cash interest expense	1,800,000	1,900,000	1,900,000	1,900,000	1,800,000	1,900,000	2,000,000	2,200,000	2,100,000	1,500,000	1,600,000	1,500,000	1,600,000	1,600,000	22,000,000	22,000,000	22,500,000	22,200,000	22,000,000	21,700,000	17,600,000	12,700,000	12,500,000	12,300,000	12,200,000	3,800,000	3,800,000	3,700,000	3,600,000
deferred income taxes	-8,900,000	-5,800,000	24,300,000	-11,600,000	-14,700,000	-41,800,000	81,500,000	-85,000,000	-42,200,000	-9,300,000	32,000,000	-33,800,000	-19,900,000	100,000	-5,100,000	100,000	400,000	-300,000
other non-cash income and expenses	-400,000	-12,300,000	16,000,000	-39,900,000	-15,600,000	-7,800,000	-36,600,000	-17,900,000	-15,700,000	-13,700,000	2,800,000	15,900,000	12,200,000	3,800,000	13,100,000	14,500,000	8,000,000	8,000,000	9,600,000	600,000	3,400,000	100,000	2,500,000	-2,200,000	300,000	300,000	5,600,000	-900,000
changes in operating assets and liabilities:
accounts receivable	-184,600,000	-148,900,000	-7,400,000	-55,600,000	33,800,000	-5,800,000	-187,200,000	-35,800,000	-113,700,000	76,600,000	-148,300,000	-4,500,000	-17,000,000	-30,100,000	15,100,000	-35,700,000	-40,000,000	-14,900,000	-58,500,000	-73,400,000	4,300,000	-14,700,000	-18,400,000	-12,300,000	21,500,000	-8,100,000	-38,800,000	10,700,000	-8,700,000	-15,300,000	15,800,000	-25,000,000	-3,000,000	-6,000,000	6,800,000	-18,300,000	-10,300,000	-5,300,000	2,200,000	-2,800,000	-4,700,000	2,200,000	-4,500,000	-3,800,000	-1,400,000	3,200,000	-7,190,000	543,000	-357,000	4,000	-3,544,000	-309,000	-1,536,000	-487,000	-1,569,000	-441,000	-860,000	-311,000	-1,003,000	-420,000	-722,000	-227,000	-689,000	139,000	-247,000	-106,000
inventory	-18,500,000	6,200,000	32,700,000	-1,900,000	18,300,000	-36,700,000	-59,000,000	-78,600,000	-55,400,000	-59,600,000	5,700,000	26,900,000	1,100,000	15,600,000	-6,000,000	-21,700,000	-29,500,000	-55,000,000	-33,600,000	-35,400,000	-23,300,000	-22,200,000	-2,500,000	-16,800,000	-30,400,000	-9,000,000	5,400,000	-6,400,000	-600,000	3,800,000	-1,000,000	-900,000	-1,700,000	3,700,000	-10,900,000	-4,600,000	-8,200,000	-4,000,000	-2,400,000	-2,700,000	-2,800,000	200,000	900,000	-2,700,000	300,000	-100,000	-330,000	237,000	666,000	127,000	-1,716,000	-197,000	167,000	1,687,000	-1,759,000	-2,266,000	-236,000	-1,210,000	-709,000	-569,000	1,002,000	81,000	144,000	181,000	-947,000	-685,000	-104,000
prepaid and other assets	-22,000,000	16,500,000	8,000,000	31,600,000	-56,800,000	11,400,000	6,100,000	16,600,000	10,000,000	-13,400,000	-50,400,000	1,300,000	15,400,000	-97,900,000	-3,100,000	8,900,000	-6,900,000	-20,200,000	9,400,000	14,800,000	-19,000,000	-7,600,000	800,000	2,000,000	-5,400,000	1,600,000	-2,300,000	-2,700,000	2,500,000	1,500,000	-7,700,000	200,000	-1,400,000	-1,700,000	-1,000,000			-1,200,000	200,000	1,300,000			-900,000	300,000	-700,000	-100,000	-18,000	-139,000	-412,000	-231,000	720,000	689,000	-560,000	389,000	-1,133,000	162,000	-136,000	2,395,000	-1,539,000	696,000	-563,000	402,000	-133,000	337,000	-478,000	422,000	-36,000
operating lease right-of-use assets and liabilities	-2,100,000	-900,000	-3,500,000	600,000	-1,600,000	-2,000,000	-100,000	-2,300,000	-1,400,000	-700,000	300,000	-2,700,000	-2,500,000	-900,000	0	-1,200,000	400,000	700,000	500,000	-100,000	-800,000	-400,000
accounts payable and accrued liabilities	234,000,000	125,400,000	-20,000,000	49,800,000	72,300,000	109,600,000	-30,000,000	219,500,000	190,300,000	86,700,000	123,800,000	75,300,000	42,500,000	53,500,000	-57,300,000			30,000,000	67,900,000	69,800,000	51,500,000	5,300,000	24,300,000	28,400,000	25,500,000	17,300,000	30,700,000	2,200,000	10,700,000	-300,000	2,100,000	2,500,000	9,300,000	5,600,000	3,700,000	5,000,000	9,100,000	2,100,000	1,600,000	1,700,000	4,500,000	-100,000	-500,000	2,100,000	1,300,000	-500,000	-2,066,000	2,817,000	180,000	-631,000	301,000	1,080,000	731,000	-1,116,000	-1,728,000	1,387,000	572,000	-663,000	1,372,000	255,000	344,000	-463,000	1,581,000	-1,060,000	491,000	-1,303,000
accrued payroll and related expenses	15,900,000	-600,000	4,300,000	-9,100,000	5,500,000	-60,700,000	20,600,000	42,100,000	13,800,000	-39,300,000	22,500,000	17,100,000	9,400,000	-40,500,000	9,900,000	16,700,000	16,800,000	-33,000,000	21,800,000	25,100,000	8,300,000	-29,100,000	-2,800,000	22,700,000	-21,100,000	8,200,000	12,400,000	-14,400,000	3,700,000	1,200,000	-3,300,000	6,500,000	3,700,000	6,500,000	-8,200,000	4,600,000	3,300,000	4,900,000	-5,100,000	3,700,000	2,000,000	-4,000,000	2,700,000	2,300,000	2,800,000	-2,000,000	542,000	732,000	1,679,000	-553,000	-157,000	558,000	1,700,000	-1,027,000	107,000	740,000	835,000	-358,000	846,000	402,000	971,000	72,000	-607,000	291,000	21,000	-127,000	-107,000
deferred revenue and other liabilities	-300,000	2,700,000	-7,700,000	400,000	-3,900,000	3,200,000	-8,500,000	1,500,000	3,200,000	1,200,000	-19,600,000	25,000,000	2,900,000	2,800,000	2,000,000	3,700,000	1,900,000	1,100,000	1,900,000	1,300,000	14,400,000	1,000,000	-5,000,000
net cash from operating activities	303,000,000	183,800,000	301,400,000	199,500,000	279,400,000	209,200,000	133,600,000	269,200,000	190,300,000	155,400,000	132,500,000	293,200,000	172,800,000	71,000,000	105,800,000	247,300,000	61,600,000	27,800,000	172,000,000	147,600,000	154,100,000	1,900,000	94,500,000	64,500,000	11,800,000	56,800,000	41,400,000	-8,700,000	36,200,000	14,300,000	300,000	13,300,000	23,000,000	20,100,000	-200,000	11,300,000	17,900,000	16,400,000	3,400,000	11,400,000	6,200,000	-2,400,000	4,400,000	1,600,000	900,000	-4,500,000	-10,557,000	-6,050,000	-6,329,000	-10,164,000	-11,570,000	-6,741,000	-2,526,000	-9,289,000	-13,464,000	-9,470,000	-9,305,000	-10,437,000	-9,173,000	-9,808,000	-11,036,000	-9,372,000	2,526,000	-11,617,000	-11,901,000	-16,459,000
capex	-100,000,000	-29,400,000	-124,600,000	-124,300,000	-16,100,000	-16,200,000	-52,500,000	-56,800,000	-61,400,000	-18,900,000	-63,500,000	-108,200,000	-91,500,000	-75,000,000	-80,200,000	-121,100,000	-93,000,000	-64,700,000	-60,200,000	-36,600,000	-60,800,000	-13,600,000	15,200,000	-49,900,000	-29,200,000	-27,100,000	-8,300,000	-11,000,000	-11,900,000	-12,700,000	-17,300,000	-17,600,000	-16,100,000	-10,500,000	-11,500,000	-11,600,000	-7,400,000	-6,300,000	-8,000,000	-3,700,000	-4,000,000	-3,900,000	-2,300,000	-2,200,000	-2,000,000	-1,400,000	-1,404,000	-2,894,000	-2,882,000	-2,320,000	-3,549,000	-1,506,000	-1,160,000	-1,791,000	-2,326,000	-2,093,000	-1,483,000	-958,000	-463,000	-825,000	-754,000	-950,000	-431,000	-609,000	-392,000	-1,060,000
free cash flows	203,000,000	154,400,000	176,800,000	75,200,000	263,300,000	193,000,000	81,100,000	212,400,000	128,900,000	136,500,000	69,000,000	185,000,000	81,300,000	-4,000,000	25,600,000	126,200,000	-31,400,000	-36,900,000	111,800,000	111,000,000	93,300,000	-11,700,000	109,700,000	14,600,000	-17,400,000	29,700,000	33,100,000	-19,700,000	24,300,000	1,600,000	-17,000,000	-4,300,000	6,900,000	9,600,000	-11,700,000	-300,000	10,500,000	10,100,000	-4,600,000	7,700,000	2,200,000	-6,300,000	2,100,000	-600,000	-1,100,000	-5,900,000	-11,961,000	-8,944,000	-9,211,000	-12,484,000	-15,119,000	-8,247,000	-3,686,000	-11,080,000	-15,790,000	-11,563,000	-10,788,000	-11,395,000	-9,636,000	-10,633,000	-11,790,000	-10,322,000	2,095,000	-12,226,000	-12,293,000	-17,519,000
investing activities
purchases of marketable securities	-608,200,000	-462,500,000		-306,900,000	-784,200,000	-992,400,000		-798,000,000	-1,340,300,000	-809,600,000		-254,000,000	-597,200,000	-546,500,000		-368,300,000	-369,900,000	-802,000,000		-403,100,000	-1,374,200,000	-365,800,000
proceeds from sale and maturity of marketable securities	638,700,000	650,200,000	405,200,000	630,600,000	666,800,000	1,121,800,000	719,000,000	671,400,000	859,400,000	697,600,000	740,000,000	602,200,000	543,800,000	241,800,000	501,000,000	537,000,000	838,300,000	790,000,000	952,000,000	449,000,000	319,500,000	530,000,000	259,200,000	291,300,000	222,500,000
purchases of property and equipment	-94,100,000	-87,000,000	-124,600,000	-111,200,000	-66,100,000	-56,900,000	-52,500,000	-50,400,000	-59,000,000	-74,700,000	-63,500,000	-108,200,000	-91,500,000	-101,600,000	-80,200,000	-108,100,000	-101,200,000	-99,700,000	-60,200,000	-47,400,000	-58,200,000	-33,200,000
other investing activities	0	-500,000	-10,200,000	-2,200,000	-5,400,000	2,300,000	900,000	-2,500,000			-2,000,000	-10,000,000	0	-2,300,000	14,600,000	0	-4,000,000	-500,000	-700,000	-7,800,000	-2,400,000	-400,000
net cash from investing activities	-63,600,000	100,200,000	-303,700,000	210,300,000	-188,900,000	74,800,000	414,900,000	-179,500,000	-555,900,000	-186,700,000	-194,100,000	229,300,000	-144,900,000	-411,800,000	-496,100,000	29,000,000	363,200,000	-112,200,000	-24,000,000	-9,300,000	-1,115,300,000	130,600,000	-412,800,000	-639,400,000	131,300,000	4,600,000	-159,900,000	-15,400,000	-36,600,000	-85,300,000	-21,400,000	-17,300,000	-17,800,000	-9,600,000	-11,200,000	-12,700,000	-5,700,000	-7,200,000	-25,900,000	-3,800,000	-4,000,000	-4,300,000	500,000	1,700,000	6,100,000	12,600,000	6,553,000	3,494,000	6,722,000	11,631,000	-3,446,000	-10,602,000	-39,099,000	6,776,000	-20,429,000	7,327,000	3,513,000	-16,021,000
financing activities
net proceeds from issuance of common stock	0	14,200,000	0	14,800,000	0	13,400,000	0	14,300,000	0	12,300,000	0	12,400,000	0	10,100,000	0	11,600,000	0	8,700,000	0	8,600,000	0	6,700,000	6,800,000	100,000	5,000,000	5,400,000	1,000,000	4,200,000	4,300,000	400,000	5,300,000	500,000	5,100,000	1,000,000	3,800,000	2,800,000	5,900,000	4,900,000	5,500,000	6,600,000	2,200,000	9,700,000	5,100,000	1,900,000	2,300,000	2,700,000	694,000	1,334,000	452,000	1,120,000	47,000	1,033,000	71,941,000	1,688,000	33,485,000	1,850,000	1,397,000	33,814,000	79,000	343,000	78,000	45,810,000	66,000	384,000	259,000	1,053,000	207,000
other financing activities	-1,700,000	-1,700,000	-1,600,000	-1,300,000	-1,400,000	-8,700,000	4,900,000	-1,200,000	-1,100,000	-1,100,000	-1,000,000	-7,200,000	-4,300,000	-4,800,000	-800,000	-800,000	-400,000	-7,900,000	-4,900,000	-4,100,000	-200,000	-200,000	-100,000	-200,000	-100,000
net cash from financing activities	-1,700,000	12,500,000	-1,600,000	-736,500,000	-1,400,000	4,700,000	-631,900,000	-637,400,000	939,500,000	11,200,000	-1,000,000	-552,500,000	-4,300,000	5,300,000	-800,000	10,800,000	-400,000	800,000	-4,900,000	4,500,000	906,000,000	6,500,000	6,000,000	-100,000	4,900,000	5,400,000	-800,000	4,200,000	4,300,000	314,400,000	80,300,000	500,000	5,100,000	-700,000	3,200,000	2,200,000	5,400,000	4,300,000	4,900,000	6,100,000	1,600,000	9,200,000	4,900,000	1,900,000	2,300,000	2,700,000	7,294,000	1,334,000	452,000	1,120,000	47,000	958,000	71,716,000	1,463,000	33,260,000	1,625,000	1,172,000	33,589,000	-146,000	-226,000	-491,000	45,242,000	-503,000	-185,000	-310,000	3,710,000	-204,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	16,500,000	2,300,000	-11,200,000	8,600,000	-1,000,000	-3,800,000	6,100,000	-3,500,000	-2,200,000	1,100,000	6,800,000	-7,300,000	-4,300,000	-1,000,000	-500,000	-1,000,000	500,000	-400,000	1,300,000	1,000,000	300,000	-500,000	-1,400,000	-900,000	600,000	400,000	-900,000	-900,000
increase in cash, cash equivalents and restricted cash	254,200,000	298,800,000	-15,100,000	-318,100,000	88,100,000	284,900,000	-77,300,000	-551,200,000			-55,800,000	-37,300,000			-391,600,000	286,100,000	424,900,000	-84,000,000	144,400,000	143,800,000	-54,900,000	138,500,000			148,600,000	67,200,000	-120,200,000	-20,800,000
cash, cash equivalents and restricted cash, beginning of period	0	607,300,000	0	0	0	567,500,000	0	0	0	643,300,000	0	0	0	1,053,600,000	0	0	0	818,200,000	0	0	0	446,400,000	0	0	1,137,100,000	0	0	441,500,000
cash, cash equivalents and restricted cash, end of period	254,200,000	906,100,000	-15,100,000	-318,100,000	88,100,000	852,400,000	-77,300,000	-551,200,000	571,700,000	624,300,000	-55,800,000	-37,300,000	19,300,000	717,100,000	-391,600,000	286,100,000	424,900,000	734,200,000	144,400,000	143,800,000	-54,900,000	584,900,000	-313,700,000	-575,900,000	1,285,700,000	67,200,000	-120,200,000	420,700,000
reconciliation of cash, cash equivalents and restricted cash, end of period:
cash and cash equivalents	254,100,000	904,900,000	-15,100,000	-318,000,000	88,000,000	851,200,000	-77,400,000	-551,200,000	571,700,000	623,200,000	-55,800,000	-37,300,000	19,400,000	716,000,000	-391,700,000	285,500,000	425,000,000	733,800,000	144,100,000	143,500,000	-54,600,000	584,600,000	-313,600,000	-575,900,000	1,285,100,000
restricted cash	100,000	1,200,000	0	-100,000	100,000	1,200,000	100,000	0	0	1,100,000	0	0	-100,000	1,100,000	100,000	600,000	-100,000	400,000	300,000			300,000	-100,000	0	600,000	0	0	300,000								0	700,000										0	0	0	-100,000	0	325,000	225,000	225,000	225,000	225,000	25,000	225,000	225,000	569,000	494,000	568,000	569,000	569,000	569,000	-5,063,000
total cash, cash equivalents and restricted cash	254,200,000	906,100,000	-15,100,000	-318,100,000	88,100,000	852,400,000	-77,300,000	-551,200,000	571,700,000	624,300,000	-55,800,000	-37,300,000	19,300,000	717,100,000	-391,600,000	286,100,000	424,900,000	734,200,000	144,400,000	143,800,000	-54,900,000	584,900,000	-313,700,000	-575,900,000	1,285,700,000
supplemental disclosure of non-cash investing and financing transactions:
acquisition of property and equipment included in accounts payable and accrued liabilities	-5,900,000	57,600,000		-13,100,000	50,000,000	40,700,000		-6,400,000	-2,400,000	55,800,000				26,600,000		-13,000,000	8,200,000	35,000,000		10,800,000	-2,600,000	19,600,000	15,200,000	-3,000,000	10,100,000	-3,300,000	2,000,000	4,300,000	1,600,000	-700,000	5,600,000
right-of-use assets obtained in exchange for operating lease liabilities				-500,000	7,600,000	1,100,000		1,900,000	2,200,000	1,900,000				-1,300,000		1,800,000	500,000	9,900,000
right-of-use assets obtained in exchange for finance lease liabilities	300,000	1,100,000		2,000,000	2,400,000	7,400,000		300,000	500,000	1,000,000				5,200,000		1,700,000
purchase of marketable securities																								-883,800,000	-50,700,000
acquisitions, net of cash acquired											0	-700,000	0	-3,200,000	1,400,000																	-100,000	0			0	0
purchases of non-marketable equity securities
purchases of treasury stock			0				-500,000,000	0			0
proceeds from issuance of convertible notes, net of issuance costs																			0	0
purchases of capped call transactions							0	0
payments for conversions of senior convertible notes							-136,800,000
proceeds from issuance of senior convertible notes, net of issuance costs								0
shares issued for conversions of 2023 notes														35,900,000
shares received under note hedge upon conversion of 2023 notes
collaborative research and development fee
loss on extinguishment of debt															700,000				0	500,000
realized (gain) loss on equity investment							-900,000				0	0	0	-200,000
decrease in cash, cash equivalents and restricted cash										-19,000,000				-336,500,000									-313,700,000
repurchase of convertible notes																			0	0
shares received under note hedge upon conversions of 2023 notes														-33,500,000
* we adjusted our 2021 amounts to reflect the simplified convertible instruments accounting guidance, which we adopted on a full retrospective basis. refer to note 1 “organization and significant accounting policies” for further information.
shares issued for repurchase and conversions of senior convertible notes
common stock issued for repurchase and conversions of senior convertible notes																				160,900,000
non-cash collaborative research and development fee through issuance of common stock
unrealized gain on equity investment																												-7,400,000
proceeds from sale of warrants
purchase of convertible note hedge
realized loss on equity investment
cash flows from investing activities:
cash flows from financing activities:
right-of-use assets obtained in exchange for lease liabilities																					0	5,300,000	1,400,000	10,600,000	45,200,000
purchases of other equity investments
cash flows from operating activities:
unrealized (gain) loss on equity investment
payments on acquisition related contingent consideration liability																										0
(income) income from equity investments																								0	4,200,000
purchase of other equity investments																								0	-1,200,000	0	0	-1,000,000
purchase of property and equipment																								-46,900,000	-39,300,000	-23,800,000	-10,300,000	-15,300,000	-13,500,000	-12,000,000	-22,900,000	-17,600,000	-16,100,000	-10,500,000	-11,500,000	-11,600,000	-7,400,000	-6,300,000	-8,000,000	-3,700,000	-4,000,000	-3,900,000	-2,300,000	-2,200,000	-2,000,000	-1,400,000	-1,404,000	-2,894,000	-2,882,000	-2,320,000	-3,549,000	-1,506,000	-1,160,000	-1,791,000	-2,326,000	-2,093,000	-1,483,000	-958,000	-463,000	-825,000	-754,000	-950,000	-431,000	-609,000	-392,000	-1,060,000
deferred revenue, deferred rent, and other liabilities																									-3,000,000
unrealized income on equity investment																										9,300,000
realized income on equity investment
deferred tax																													-1,100,000
deferred revenue																										-3,300,000	3,900,000	-300,000	900,000	300,000	200,000	400,000	-100,000	0	-200,000	-800,000	800,000	-500,000	600,000	300,000	-300,000	-100,000	200,000	-100,000	-200,000	-1,100,000	181,000	-410,000	-478,000	807,000	135,000	-596,000	-596,000	-595,000	-917,000	394,000	-1,721,000	-1,977,000	-957,000	-1,355,000	-1,564,000	-399,000	11,641,000	-42,000	-42,000	463,000
deferred rent and other liabilities																										-700,000	900,000	400,000	400,000	300,000	1,200,000	2,700,000	1,300,000	700,000	200,000	-400,000	1,900,000	400,000	500,000	-100,000	-100,000	-100,000	-200,000	0			501,000	-88,000	-32,000	119,000	-22,000	-33,000	-9,000	-15,000	70,000	222,000	-41,000	-49,000	2,000	-42,000	-36,000	27,000	210,000	0	6,000	7,000
proceeds from issuance of convertible debt, net of issuance costs																													0
proceeds from short-term borrowings																													0	0	75,000,000
repayment of short-term borrowings																													0
reconciliation of cash, cash equivalents and restricted cash:
purchase of available-for-sale marketable securities																											-192,100,000	-32,000,000	-50,500,000	-84,000,000	-7,400,000	-9,100,000	-9,200,000	-10,100,000	-10,800,000	-9,800,000	-7,900,000	-4,900,000	-22,600,000	-3,900,000	-3,400,000	-3,000,000	-3,900,000	-3,500,000	-4,000,000	-4,900,000	-10,118,000	-13,999,000	-15,665,000	-26,618,000	-24,611,000	-28,614,000	-45,439,000	-3,991,000	-29,759,000	-4,033,000	-7,390,000	-32,265,000	-11,673,000	-5,192,000	-3,044,000	-45,361,000	-4,036,000	-8,000	-15,378,000	-17,564,000
proceeds from the maturity of available-for-sale marketable securities																											42,500,000	32,900,000	27,400,000	10,700,000	8,900,000	9,500,000	7,500,000	10,600,000	11,100,000	8,700,000	9,600,000	4,500,000	4,700,000	3,800,000	3,400,000	2,600,000	6,700,000	7,400,000	12,100,000	18,900,000	18,075,000	20,387,000	25,269,000	40,569,000	24,710,000	19,518,000	7,500,000	12,558,000	11,650,000	13,453,000	12,386,000	17,202,000	18,373,000	18,200,000	10,283,000	7,000,000	10,501,000	12,099,000	8,992,000	32,210,000	31,540,000
reconciliation of cash and restricted cash:
cash																											-120,200,000	420,400,000
total cash and restricted cash																											-120,200,000	420,700,000
other non-cash expenses																													-2,900,000	5,700,000	400,000											100,000
repayment of long-term debt																																0	0	-1,700,000	-600,000	-600,000	-500,000	-600,000	-600,000	-500,000	-600,000	-500,000
effect of exchange rate changes on cash and cash equivalents																													2,300,000	-1,000,000	-200,000		-100,000														19,000	-19,000	21,000	-21,000	-1,000	19,000	-7,000	-34,000	-7,000	-43,000	10,000	-8,000	-5,000	5,000	-26,000	17,000
increase in cash and cash equivalents																													6,200,000	242,400,000	59,000,000	-3,200,000	10,200,000			800,000	17,600,000	13,500,000	-17,600,000	13,700,000	3,800,000	2,500,000	9,800,000	5,200,000	9,300,000	10,800,000	3,309,000	-1,241,000	866,000	2,566,000	-14,970,000	-16,366,000	30,084,000	-1,084,000	-640,000	-561,000	-4,610,000	7,123,000				-3,424,000	8,058,000	-321,000	-18,989,000	837,000
cash and cash equivalents, beginning of period																													0	0	94,500,000	0	0	0	86,100,000	0	0	0	71,800,000	0	0	43,200,000	0	0	0	8,100,000		0	0	2,553,000		0	0	4,889,000		0	0	3,577,000		0	0	12,700,000		0	0	23,115,000
cash and cash equivalents, end of period																													6,200,000	242,400,000	153,500,000		10,200,000	9,600,000	77,900,000		17,600,000	13,500,000	54,200,000													-16,366,000
issuance of common stock in connection with acquisition																																0	0
acquisition-related holdback liability																																0	0
assets acquired and financing obligation under build-to-suit leasing arrangement																																0	0
non-cash research and development charge through issuance of common stock																																				0
impairment of intangible assets
cash and cash equivalents, ending of period																																									3,800,000	45,700,000	9,800,000	5,200,000	9,300,000	18,900,000		-1,241,000	866,000	5,119,000				3,805,000		-561,000	-4,610,000	10,700,000		2,154,000	-5,068,000	9,276,000		-321,000	-18,989,000	23,952,000
supplemental disclosure of cash flow information
cash paid during the year for interest
cash paid during the year for taxes
issuance of common stock in connection with contingent consideration settlement
accretion and amortization related to marketable securities																																	100,000	0	100,000	0	100,000	100,000	100,000	0			0	100,000
amortization of debt issuance costs																																				0	100,000	0	100,000	100,000	100,000	100,000	100,000	100,000							0	0			0	6,000	24,000	6,000	68,000	-19,000	145,000	52,000	134,000	138,000	135,000	139,000	139,000
loss on disposal of equipment																																					100,000	0	200,000
decrease in cash and cash equivalents																																			-8,200,000																									2,154,000
change in fair value of contingent consideration																																								-900,000	-1,000,000	1,200,000	500,000	1,000,000	700,000	300,000	-240,000	278,000
adjustments to reconcile net income to cash from in operating activities:
release of valuation allowance against deferred tax assets																																															16,000	0	0	-1,316,000
net proceeds from issuance of long-term debt
repayment of equipment loan																																															0	0	0	0	0	-75,000	-225,000	-225,000	-225,000	-225,000	-225,000	-225,000	-225,000	-569,000	-569,000	-568,000	-912,000	-569,000	-226,000	-343,000
supplemental disclosure of non-cash transactions
issuance of common stock in connection with acquisition and contingent consideration																																																0	0	6,063,000
accretion and amortization related to investments																																														100,000	136,000	166,000	213,000	285,000	299,000	294,000	170,000	146,000	149,000	191,000	227,000	154,000	128,000	238,000	334,000	191,000	27,000	21,000	-10,000	-37,000
accretion of non-cash interest expense related to convertible notes																																																			0	0
loss on debt extinguishment upon conversion of convertible debt																																																			0	0			3,000	312,000	245,000	7,930,000
cash and cash equivalents, beginning of year
cash and cash equivalents, ending of year
supplemental disclosure of cash flow information:
non-cash investing and financing transactions:
conversion of convertible notes to common stock																																																			0	0			-763,000	4,001,000	1,549,000	41,483,000
other non-cash																																																	-60,000	61,000
non-cash restructuring charge
proceeds from the sale of equipment
unrealized gain on marketable securities
accretion related to convertible debt discount																																																								51,000	89,000	919,000		1,241,000	1,186,000	1,135,000
compensation expense associated with stock options issued to consultants
proceeds from equipment loan																																																															343,000	0	-343,000	3,000,000	0
non-cash restructuring benefit																																																												0	0	-362,000
proceeds from issuance of senior convertible notes																																																																			0
payment of senior convertible notes issuance costs
purchase of senior convertible notes call spread options
net cash provided by/(used in) investing activities																																																												12,183,000	6,485,000	-39,311,000		11,482,000
common shares received as settlement for a call spread option																																																																0	0	869,000
stock-based compensation
net cash provided/(used) in investing activities																																																																		13,586,000
conversion of series a, b, c, and d preferred stock
accretion to redemption value of series b, series c, and series d redeemable convertible preferred stock
other assets
other liabilities
non-cash investing and financing activities
deferred rent
net proceeds from issuance of preferred stock
interest on converted notes
prepaid and other current assets
proceeds on sale of equipment
proceeds from convertible notes payable
purchase of technology in exchange for common stock
conversion of notes payable into series b preferred stock
unrealized loss on marketable securities

We provide you with 20 years of cash flow statements for DexCom stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DexCom stock. Explore the full financial landscape of DexCom stock with our expertly curated income statements.

The information provided in this report about DexCom stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.